comparemela.com

Latest Breaking News On - Phathom pharmaceuticals stock - Page 1 : comparemela.com

Phathom Pharmaceuticals (PHAT) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […]

Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) Short Interest Up 18 2% in November

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 4,870,000 shares, an increase of 18.2% from the October 31st total of 4,120,000 shares. Based on an average daily volume of 467,100 shares, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.